Sane D, Feldman J: Cutaneous signs of cardiopulmonary disease. A Blush iron the heart. Chest 1987; 92(2): 360-1.

https://doi.org/10.1378/chest.92.2.360

Maton P: The carcinoid syndrome. JAMA 1988; 260(11): 1602-5.

https://doi.org/10.1001/jama.1988.03410110110038

Ludin L, Norheim I, Landelius J, et al: Carcinoid heart disease: Relationship of circulating vasoactive substances to ultrasound - Detectable cardiac abnormalities. Circulation 1988; 77(2): 264-9.

https://doi.org/10.1161/01.CIR.77.2.264

Himelman R, Schiller N: Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. Am J Cardiol 1989; 63: 347-352.

https://doi.org/10.1016/0002-9149(89)90344-5

Noppen M, Jacobs A, Van Belles, et al: Inhibitory effects of ranitidine on flushing and serum serotonine concentrations in carcinoid syndrome. Br Med J 1988; 296: 682-3.

https://doi.org/10.1136/bmj.296.6623.682-a

Gutman H, Deutsch A, Leiser A et al: Primary duodenal carcinoid with malignant carcinoid syndrome: A case report. Am J Gastroent 1986; 81(2): 112-4.

Lucas K, Feldman J: Flushing in the carcinoid syndrome and plasma kallikrein. Cancer 1986; 58(10): 2290-3.

https://doi.org/10.1002/1097-0142(19861115)58:10<2290::AID-CNCR2820581022>3.0.CO;2-4

Feldman J, O'dorisio T: Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986; 81(SuppI 6B): 41-8.

https://doi.org/10.1016/0002-9343(86)90583-8

Levine R, Sjoerdsma A: Ptessor amines and the carcinoid flush. Ann Int Med 1963; 58(5): 818-828.

https://doi.org/10.7326/0003-4819-58-5-818

Gallahan J, Wroblenski E, Reeder G, et al: Echocardiographic features of carcinoid heart Disease. Am J Cardiol 1982; 50: 762-8.

https://doi.org/10.1016/0002-9149(82)91231-0

Ross E, Roberts W: The carcinoid syndrome: Comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 1985; 79: 339-354.

https://doi.org/10.1016/0002-9343(85)90313-4

Reid C, Chandraratna P, Kawanishi D, et al: Echocardiographic features of carcinoid heart disease. Am Heart J 1984; 107(4); 801-3.

https://doi.org/10.1016/0002-8703(84)90339-9

Forman M, Byrd B, Oates J, et al: Two - dimensional echocardiography in the diagnosis of carcinoid heart disease. Am Heart J 1984; 107(3): 492-6.

https://doi.org/10.1016/0002-8703(84)90091-7

Baker B, Menee V, Scovil J, et al: Tricuspid insufficiency in carcinoid heart disease: An echocardiography description. Am Heart J 1981; 107-8.

https://doi.org/10.1016/0002-8703(81)90389-6

Tiell E, Rausing A, Ripa J, et al: Carcinoid heart disease. Qinicopathologic findings and follow up on 11 cases. Am J Med 1973; 54: 433-445.

https://doi.org/10.1016/0002-9343(73)90039-9

Schiller V, Fishbein M, Siegel R, et al: Unusual cardiac involvement in carcinoid syndrome. Am Heart J 1986; 112(6): 1322-3.

https://doi.org/10.1016/0002-8703(86)90369-8

Leitner S, Greenberg P, Danieu L, et al: Partial remision of carcinoid tumor in response to cyproheptadine. Ann Int Med 1989; 111(9): 760-1.

https://doi.org/10.7326/0003-4819-111-9-760

Kvols L: Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemoterapy and hormonal therapy. Am J Med 1986; 81(SuppI 6B): 49-55.

https://doi.org/10.1016/0002-9343(86)90584-X

Marsh H, Martin J, Kvols L, et al: Carcinoid crisis during anesthesia: Successful treatment with a somatostatin analogue. Anesthesiology 1987; 66(1): 89-91.

https://doi.org/10.1097/00000542-198701000-00021

Kvols L, Martin J, Marsh H, et al: Rapid reversal of carcinoid crisis with a somatostatin analogue. N Engl J Med 1985; 313(19): 1229-1230.

https://doi.org/10.1056/NEJM198511073131916

Smith S, Anthony L, Roberts L, et al: Resolution of musculoskeletal symptoms in the carcinoid syndrome after treatment with the somatostatin analog octreotide. Ann Int Med 1990; 112(1): 66-68.

https://doi.org/10.7326/0003-4819-112-1-66

Kvols L, Moertel G O'Connel M, et al: Treatment of the malignantcarcinoid syndrome evaluation of a long-acting somatostatin analogue. N Engl Med 1986; 315(11): 663-666.

https://doi.org/10.1056/NEJM198609113151102

Altman A. Tschen J, Rice L, et al: Treatment of malignant carcinoid syndrome with a long acting somatostatin analogue. Arch Dermatol 1989; 125: 394-396.

https://doi.org/10.1001/archderm.1989.01670150084014

Raymond PL, Balca MA: Diplopia and diarrhea: Ileal carcinoid mestastic to the central nervous system. Am J Gastroent 1992; 87(2): 240-3.

Asbun HJ, et al: Thynic carcinoid. Am Surgeon 1991; 57(7): 442-5.

MC Crirrick A, Hickman J: Octreotide for carcinoid syndrome. Canadian J Anaesthesia 1991; 38(4pt1): 539-40.

https://doi.org/10.1007/BF03007600

Lebovics E, Rosenthal WS: Glucagon precipitation of carcinoid flush. Gastrointestinal endoscopy 1991; 37(2): 212-3.

https://doi.org/10.1016/S0016-5107(91)70700-1

Moulopoulos A, et al: Primary renal carcinoid. Computed tomography, ultrasound, and angiographic findings. Journal of computer assisted tomography 1991; 15(2): 323-5.

https://doi.org/10.1097/00004728-199103000-00028

Amundson DE, Weiss PJ: Hyporxemia in malignant carcinoid syndrome a case attributed to occult lymphangitic metastatic involvement. Mayo Clinic Proceedings 1991; 66(11): 1178-80.

https://doi.org/10.1016/S0025-6196(12)65802-9

Paties C, Zangradi A, Vasallo G, Ringi G, Solcia E: Multidirectional carcinoma of the thymus with neuroendocrine and sarconatoid components and carcinoid syndrome. Pathology, Research & Practice 1991; 187(2-3): 170-7

https://doi.org/10.1016/S0344-0338(11)80767-3